{"symbol": "ATNM", "companyName": "Actinium Pharmaceuticals Inc. (Delaware)", "exchange": "NYSE American", "industry": "Biotechnology", "website": "https://www.actiniumpharma.com", "description": "Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's product portfolio includes Iomab-B and Actimab-A.", "CEO": "Sandesh Seth", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}